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The Campylobacter jejuni Response Regulator, CbrR, Modulates Sodium
Deoxycholate Resistance and Chicken Colonization
Abstract
Two-component regulatory systems play a major role in the physiological response of bacteria to
environmental stimuli. Such systems are composed of a sensor histidine kinase and a response regulator
whose ultimate function is to affect the expression of target genes. Response regulator mutants of
Campylobacter jejuni strain F38011 were screened for sensitivity to sodium deoxycholate. A mutation in
Cj0643, which encodes a response regulator with no obvious cognate histidine kinase, resulted in an absence
of growth on plates containing a subinhibitory concentration of sodium deoxcholate (1%, wt/vol). In broth
cultures containing 0.05% (wt/vol) sodium deoxycholate, growth of the mutant was significantly inhibited
compared to growth of the C. jejuni F38011 wild-type strain. Complementation of the C. jejuni cbrR mutant in
trans restored growth in both broth and plate cultures supplemented with sodium deoxycholate. Based on the
phenotype displayed by its mutation, we designated the gene corresponding to Cj0643 as cbrR
(Campylobacter bile resistance regulator). While the MICs of a variety of bile salts and other detergents for the
C. jejuni cbrR mutant were lower, no difference was noted in its sensitivity to antibiotics or osmolarity. Finally,
chicken colonization studies demonstrated that the C. jejuni cbrR mutant had a reduced ability to colonize
compared to the wild-type strain. These data support previous findings that bile resistance contributes to
colonization of chickens and establish that the response regulator, CbrR, modulates resistance to bile salts in
C. jejuni.
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Two-component regulatory systems play a major role in the physiological response of bacteria to environ-
mental stimuli. Such systems are composed of a sensor histidine kinase and a response regulator whose
ultimate function is to affect the expression of target genes. Response regulator mutants of Campylobacter jejuni
strain F38011 were screened for sensitivity to sodium deoxycholate. A mutation in Cj0643, which encodes a
response regulator with no obvious cognate histidine kinase, resulted in an absence of growth on plates
containing a subinhibitory concentration of sodium deoxcholate (1%, wt/vol). In broth cultures containing
0.05% (wt/vol) sodium deoxycholate, growth of the mutant was significantly inhibited compared to growth of the
C. jejuni F38011 wild-type strain. Complementation of the C. jejuni cbrRmutant in trans restored growth in both
broth and plate cultures supplemented with sodium deoxycholate. Based on the phenotype displayed by its
mutation, we designated the gene corresponding to Cj0643 as cbrR (Campylobacter bile resistance regulator).
While the MICs of a variety of bile salts and other detergents for the C. jejuni cbrR mutant were lower, no
difference was noted in its sensitivity to antibiotics or osmolarity. Finally, chicken colonization studies dem-
onstrated that the C. jejuni cbrR mutant had a reduced ability to colonize compared to the wild-type strain.
These data support previous findings that bile resistance contributes to colonization of chickens and establish
that the response regulator, CbrR, modulates resistance to bile salts in C. jejuni.
Campylobacter jejuni is a leading reported cause of bacterial
gastroenteritis worldwide. Campylobacteriosis is characterized
by diarrhea containing blood and leukocytes. The pathogenesis
of campylobacteriosis involves the destruction of colonic epi-
thelium and invasion of the lamina propria by the bacterium.
The infectious dose of C. jejuni is variable but has been re-
ported to be as low as 800 organisms (9). Thus, C. jejuni must
be able to resist a variety of antimicrobial factors found in the
digestive system of its host, including pH variations, digestive
enzymes, and bile.
Bile is secreted by the liver and is composed primarily of bile
salts and to a lesser extent phospholipids and cholesterol (12).
The primary bile salts are cholic acid, glycocholic acid, deoxy-
cholic acid, and taurocholic acid, and deoxycholic acid consti-
tutes approximately 15% of the total (16). The average con-
centration of bile salts in the human intestine ranges from 0.2
to 2% (16). In chickens, a natural host for C. jejuni, the con-
centration of bile salts ranges from 0.01% in the cecum to 0.7%
in the jejunum (28). While bile salts aid the host in the diges-
tion of fats, they also serve as an effective antimicrobial agent
by disaggregating the lipid bilayer of cellular membranes (19).
In gram-negative bacteria, bile salts can pass directly across the
outer membrane or pass through porins (e.g., OmpF in Esch-
erichia coli) (36). Thus, enteric pathogens have developed
mechanisms to resist the damaging effects of bile salts.
In C. jejuni, the only characterized mechanism of bile salt
resistance is active efflux as a function of the multidrug efflux
pump CmeABC (27, 28). A C. jejuni cmeB mutant shows in-
creased sensitivity to antimicrobial agents, including different
classes of antibiotics, detergents, and heavy metal-containing
salts. The C. jejuni cmeB mutant is 64-fold more sensitive to
sodium deoxycholate than a wild-type strain and is unable to
colonize the intestines of experimentally inoculated chickens
(28).
One mechanism that bacteria use to sense and respond to
the presence of bile (salts) includes a two-component regula-
tory (TCR) system (19). The TCR paradigm involves two com-
ponents, a histidine/sensor kinase (HK) and a cytoplasmic pro-
tein termed the response regulator (RR) (4, 24). A typical HK
consists of two functional domains, an N-terminal signal or
input domain and a C-terminal sensor kinase. The N-terminal
domain may directly interact either with a signal or with an-
other protein that serves to relay the signal to the input do-
main. In cases where the signal is external, the HK is a mem-
brane-spanning protein with a periplasmic input domain.
Upon receiving the stimulus, the signal domain activates the
C-terminal sensor kinase domain. The activated sensor kinase
hydrolyzes ATP, causing the autophosphorylation of a con-
served histidine residue in the sensor kinase domain. Upon HK
phosphorylation, interaction with the RR N-terminal receiver
domain allows transfer of the phosphate, via a phosphorelay
system, to a conserved aspartic acid residue. This phosphory-
lation activates the C-terminal output domain of the RR,
which often results in the binding of the RR to DNA via a
DNA-binding motif. This DNA binding may induce or repress
genes controlled by the TCR system. Some RRs lack a DNA-
* Corresponding author. Mailing address: School of Molecular Bio-
sciences, Washington State University, Pullman, WA 99164. Phone:
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binding domain; however, these RRs may bind other proteins,
or they may transfer a phosphate to another HK or RR.
Analysis of the C. jejuni genome has identified six HKs, 11
RRs, and an HK-RR hybrid (CheA) (31). Four of the genes
encoding C. jejuni RRs, cheY, flgR, racR, and dccR, have been
characterized to date (10, 22, 26, 29, 40, 42). Yao et al. (42)
reported that a C. jejuni cheY null mutant was nonmotile when
it was grown in semisolid media and that it was attenuated in
a ferret model, suggesting that chemotaxis is important in
establishing colonization and/or pathology in the host environ-
ment. Hendrixson and DiRita (23) showed that a cheY muta-
tion affected colonization of chickens. The racR gene of C.
jejuni was identified as the RR component associated with a
temperature-dependent signaling pathway in C. jejuni (10). A
C. jejuni racR null mutant displayed temperature-dependent
changes in its protein profile and growth characteristics, and its
ability to colonize the intestines of chickens was reduced (10).
Jagannathan et al. (26) and Hendrixson and DiRita (22)
showed that mutations in FlgR affected motility. More re-
cently, Wosten et al. (40) found that a TCR system, FlgS/FlgR,
was involved in the gene regulation of the flagellar apparatus.
Specifically, phosphorylated FlgR activates transcription of
54-dependent genes that encode the hook and basal body
structures of the flagellum. Finally, the DccRS system appears
to be required for colonization of chickens and mice; however,
it is not clear what the functions of the DccRS-controlled genes
are (29).
In this study, we sought to identify TCR systems involved in
the resistance of C. jejuni to deoxycholate. Mutations were
generated in 9 of 11 genes encoding RRs, most of which were
predicted to interact directly with the promoters of specific
target genes via a DNA-binding domain. We chose to mutate
RRs exclusively since HKs may interact with more than one
RR. Here we show that a C. jejuni cbrR mutant is unable to
survive in the presence of bile salts and other detergents and
poorly colonizes experimentally inoculated chickens.
MATERIALS AND METHODS
Bacterial strains. C. jejuni strain F38011 was grown on Mueller-Hinton (MH)
agar plates containing 5% citrated bovine blood (MH-blood) in a microaerobic
atmosphere. Where indicated below, MH-blood plates were supplemented with
either chloramphenicol (15 g/ml) or kanamycin (200 g/ml). E. coli InvF was
grown either in Luria-Bertani broth or on Luria-Bertani agar plates. When
appropriate, the plates were supplemented with chloramphenicol (15 g/ml) or
kanamycin (50 g/ml).
Mutagenesis of RRs. For each RR, oligonucleotide primers (Table 1) were
used to amplify the upstream and downstream regions of the target gene such
that approximately 100 bp of the open reading frame was omitted. More specif-
ically, an approximately 600-bp fragment including the 5 region of the target
gene and its upstream nucleotide sequence was amplified using a forward primer
containing a 5 SacI site and a reverse primer containing a 5 NheI site. For
Cj0890c, Cj1024c, and Cj1608, the forward primer contained a BamHI site. For
the downstream region of the target gene, an approximately 800-bp fragment
that included the 3 region of the target gene was amplified using a forward
primer containing a 5 NheI site and a reverse primer containing a 5 SacII site.
The 5 and 3 fragments of each gene were ligated separately into pCR2.1 using
T4 ligase as described by the manufacturer (Invitrogen, Carlsbad, CA). The
recombinant plasmids were electroporated into E. coli InvF, and the recom-
binant plasmids were purified by cesium chloride centrifugation as outlined
elsewhere (33). Following purification, the fragments were ligated into SacI/
SacII-digested pBluescript SK(). In addition, a C. jejuni chloramphenicol re-
sistance cassette (800 bp) was cloned into the NheI restriction site. The recom-
binant vectors were transformed into E. coli InvF. Constructs from
chloramphenicol-resistant colonies were screened to confirm that the NheI
chloramphenicol cassette was inserted between the upstream and downstream
regions of the target gene. Final mutagenesis vectors were introduced into the C.
jejuni F38011 wild-type strain by electroporation and selected on MH-blood
plates containing chloramphenicol. Putative mutants were confirmed by PCR
using flanking upstream and downstream primers, which, due to insertion of the
CAT gene, yielded a fragment that was approximately 700 bp larger than the
fragment of the C. jejuni F38011 wild-type strain.
Complementation of the C. jejuni cbrR mutant. The cbrR open reading frame
with 477 bp of upstream sequence and 60 bp of downstream sequence was
amplified from C. jejuni strain F38011 genomic DNA using primers CJ0643FH-F
(Table 1) and CJ0644FH-R (5-GCTTCACTGTCTAGATGGCAATG). The
PCR product was cloned into the SacI site of pRY107 that harbors a kanamycin
resistance cassette (41). The resultant construct harboring the entire C. jejuni
cbrR gene with its endogenous promoter was designated pBR643. pBR643 was
electroporated into the C. jejuni cbrR mutant and selected on MH-blood plates
containing chloramphenicol and kanamycin. The presence of the shuttle plasmid
in the complemented strain, designated the cbrR(cbrR) mutant, was confirmed
TABLE 1. Oligonucleotide primers used in this study
Primer DNA sequence (5 3 3)a
CJ0285FH-F..............GAGCTCCATACAAGTAAAGGTAATAAT
CJ0285FH-R .............GCTAGCTATAACCACTCCACGAAGATC
CJ0285BH-F .............GCTAGCGCTAAAACCTAGAGTTATTAT
CJ0285BH-R.............CCGCGGCTCTACTAAATCATGGTCGA
CJ0355FH-F..............GAGCTCAATTCATACACATGCACCCG
CJ0355FH-R .............GCTAGCTAATGCCGATAAAGTATTCTCC
CJ0355BH-F .............GCTAGCCTCCAAGAACTTCAGTTATG
CJ0355BH-R.............CCGCGGCTCTATCTCTATGTTTGAGTT
CJ0643FH-F..............GAGCTCAAAATTTAAGTTCGGGTGA
CJ0643FH-R .............GCTAGCCATTAACTCCTTAGCTTCAGC
CJ0643BH-F .............GCTAGCTGGTGAAGTTGTGGATTATG
CJ0643BH-R.............CCGCGGGCACTATACCTACCTACAAG
CJ0890FH-F..............TTGGATCCTTGCAAAAATGAAAGATGG
CJ0890FH-R .............AAAGCTAGCTAAAGATATAACTTCATAACC
CJ0890BH-F .............TTGCTAGCGATAAAACAATCAATATAGC
CJ0890BH-R.............AACCGCGGGCTGAGTATTTTTTAAAGTG
CJ1024FH-F..............AAGGATCCCAAAAAGAGCAGCGATTACAG
CJ1024FH-R .............AAAGCTAGCCTTAAAGTAGCATTTCCTGTC
CJ1024BH-F .............TTGCTAGCTGGTAATATTAGAGAATTAATATCC
CJ1024BH-R.............AACCGCGGAACAGGCACTCTAACACAAGTTGC
CJ1118FH-F..............GAGCTCGTCGTTTGGTATATTTTTGC
CJ1118FH-R .............GCTAGCCGTGTCCAAGTCTTGTTAGG
CJ1118BH-F .............GCTAGCTGAAGCTTGGGATTTATTAAC
CJ1118BH-R.............CCGCGGAAAATTCCACTACCACAACC
CJ1223FH-F..............GAGCTCAGTATGTGTTCTAAAAGCCA
CJ1223FH-R .............GCTAGCCTTCATATCCCTCATCGTTT
CJ1223BH-F .............GCTAGCGGATTTTAGATGTAAAAGTTCC
CJ1223BH-R.............CCGCGGACTTCTTCATTGCTAGCATGTC
CJ1227FH-F..............GAGCTCCCTATTGATCTTAAAAATTATATAG
CJ1227FH-R .............GCTAGCCCAAATATTCAGCTGTAATTTCTGC
CJ1227BH-F .............GCTAGCGAATATCAGCTTATCATTTTAGACC
CJ1227BH-R.............CCGCGGCATTGTTAACCTCAACCCTAGCT
CJ1261FH-F..............GAGCTCTACAAGAGCATTTATAAGTAAAGTC
CJ1261FH-R .............GCTAGCATATTAAATTGCGCTAAATATTCAG
CJ1261BH-F .............GCTAGCATGGTCTTGAAGTTTGTAGAG
CJ1261BH-R.............CCGCGGAAAGAAGAAAGAGTACAAAGCTC
CJ1491FH-F..............GAGCTCTCATGTAAATATTAATATTGTTTCG
CJ1491FH-R .............GCTAGCTCCGATTACTTTACTAAAGCG
CJ1491BH-F .............GCTAGCGGCAAGAGAGATTAAAGAAATTTC
CJ1491BH-R.............CCGCGGTATAATACCAAGTTGCCCAAATC
CJ1608FH-F..............TTGGATCCTGATACCAGAGCAGAATCCTTAAAAA
AAGCC
CJ1608FH-R .............AAAGCTAGCTCATCAAACGAGTTAATAATTTCAC
CJ1608BH-F .............TTGCTAGCAAATATATTTCCTGATACTGATC
CJ1608BH-R.............AACCGCGGGCAAATGGTGATGACAACC
a The overlined sequences are restriction enzyme recognition sites. Most of the
FH-F primers encode a 5 SacI site; the exceptions are CJ0890FH-F,
CJ1024FH-F, and CJ1608FH-F, which encode a BamHI site. The FH-R primers
encode a 5 NheI site, the BH-F primers encode an NheI site, and the BH-R
primers encode a SacII site.
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by extraction of the plasmid and subsequent transformation into E. coli InvF.
Kanamycin-resistant E. coli InvF transformants were subjected to alkaline
lysis, and the extracted plasmid was compared to pBH643 by restriction enzyme
analysis.
Bacterial growth assays. In preliminary assays, concentrations of deoxycholate
greater than 1% (wt/vol) were found to be inhibitory for the C. jejuni F38011
strain. Therefore, suspensions of C. jejuni (3 l of suspensions having an optical
density at 540 nm [OD540] of 1.0) were spotted onto MH agar plates supple-
mented with 1% (wt/vol) sodium deoxycholate to identify the mutants that
displayed deoxycholate sensitivity. After 48 h of incubation at 37°C in a mi-
croaerobic atmosphere, the presence or absence of C. jejuni growth was re-
corded.
Growth assays were performed using the C. jejuni F38011 wild-type strain, the
cbrR isogenic mutant, and the complemented cbrR(cbrR) strain. In these ex-
periments, bacteria were initially inoculated into MH broth to an OD540 of 0.02
and incubated at 37°C in a microaerobic atmosphere. Aliquots were removed at
intervals to determine the OD540. In some experiments, the number of viable
bacteria was determined at various times when organisms were grown in MH
broth supplemented with sodium deoxycholate (0.5%, wt/vol). Numbers of viable
bacteria were determined by plating serial dilutions of the bacterial suspensions
and counting the resultant colonies.
Antimicrobial agent sensitivity assays. The MIC of each antimicrobial agent
was determined using a 96-well plate in which the antimicrobial agents were
twofold serially diluted. Approximately 106 bacteria were inoculated into each
well, and the plates were incubated microaerobically for 24 h. Following incu-
bation, the growth of each C. jejuni isolate was determined by measuring the
OD540. The antimicrobial agents tested included sodium deoxycholate (Fluka,
Milwaukee, WI), chenodeoxycholate (Sigma, St. Louis, MO), cholic acid
(Sigma), ox bile extract (U.S. Biochemicals, Cleveland, OH), sodium dodecyl
sulfate (SDS) (Sigma), Triton X-100 (Calbiochem, La Jolla, CA), Tween 20 (J. T.
Baker, Phillipsburg, NJ), nalidixic acid (Sigma), tetracycline (Sigma), gentamicin
(Gibco), and sodium chloride (J. T. Baker, Phillipsburg, NJ).
Chicken colonization experiments. One-day-old broiler chickens were ob-
tained from a commercial hatchery. The chickens were negative for C. jejuni as
determined by culturing cloacal swabs. Nonmedicated feed was given to the
chickens ad libitum. In trial one, three groups of chickens (15 animals/group)
were inoculated orally when they were 3 days old with approximately 105 CFU/
bird of either C. jejuni F38011, the cbrR mutant, or the cbrR(cbrR) mutant
diluted in MH broth. The second trial was performed as described above, except
that 106 CFU was used to inoculate each bird. Five chickens were sacrificed on
days 3, 6, and 9 postinoculation, and the chicken cecal contents were collected,
weighed, serially diluted, and plated on MH agar plates which contained Campy-
lobacter-specific growth supplements and selective agents (Oxoid, United King-
dom). The selective plates were pretested for suitability to recover the C. jejuni
F38011 wild-type strain and the cbrR mutant from feces before the chicken
experiments were performed. Data are expressed as log CFU/g feces. Represen-
tative Campylobacter colonies recovered from each group of chickens were se-
lected for confirmation of identity by PCR and growth on appropriate antibiotic-
containing culture media.
Motility assays. Each C. jejuni RR mutant was tested for motility in semisolid
MH medium plates containing 0.3% agar. The plates were incubated microaero-
bically, and zones of growth were measured after incubation for 48 h.
Statistical analysis. In assays involving survival of the C. jejuni F38011, cbrR,
and cbrR(cbrR) strains in the presence of deoxycholate, we utilized the Stu-
dent’s t test to determine statistical significance at each time. P values are
indicated below.
RESULTS
Generation of RR mutants. Studies with several pathogenic
bacteria, including Salmonella spp., Shigella spp., and Vibrio
cholerae, have shown that bile salts induce an adaptive re-
sponse to the host environment (reviewed in reference 19). In
Salmonella spp. and V. cholerae, TCR systems that control the
expression of virulence genes respond to changes in bile salts,
which therefore act as host microenvironment-specific signals
(reviewed in reference 19). Therefore, based on such work with
other pathogenic bacteria, we hypothesized that a TCR system
was involved in the adaptation of C. jejuni from an environ-
ment without bile salts to an environment with bile salts. Anal-
ysis of the C. jejuni NCTC 11168 genome revealed the pres-
ence of 11 putative RRs (31). Also present in this organism is
CheA, which contains both an HK domain and an RR domain.
We did not generate a cheA mutant as the role of this gene in
chemotaxis and motility (11, 18, 21) is well established. We
were successful in generating mutants with mutations in 9 of
the 11 RRs (Table 2).
Mutations in Cj0355c and Cj1227c could not be generated
after repeated attempts. It is noteworthy that the Cj0355c
product exhibits 60% amino acid identity with the product of a
Helicobacter pylori gene, HP1043, which binds promoters that
are regulated by growth phase (13). Attempts by other inves-
tigators to generate a mutation in HP1043 have not been
successful, suggesting that this gene may be required for the
organism’s viability (7). Based on the homology of Cj0355c
with HP1043, we speculate that Cj0355c may play a similar role
in C. jejuni. Mutation of Cj1227 was attempted in several
strains (F38011, NCTC 11168, and 81116) without success.
However, construction of a merodiploid containing both a
wild-type allele and a mutant allele of Cj1227 was possible in C.
jejuni strain 480, whereas a recombinant containing two mu-
tated alleles was not recovered (M. Emery and J. Ketley, un-
published data). As this mutant retained a wild-type copy of
the gene, we did not use it in the current study. Notably, there
is no H. pylori homolog for Cj1227c.
In agreement with previous reports, Cj0285c (cheV), Cj1118c
(cheY), and Cj1024 (flgR) RR mutants were found to be non-
motile on semisolid MH agar (18, 21, 22, 26, 40, 42). A mutant
with a mutation in Cj1608 was also nonmotile. All other mu-
tants displayed motility similar to that of the C. jejuni F38011
wild-type strain (Table 2).
Identification of a C. jejuni deoxycholate-sensitive mutant.
As an initial screen for C. jejuni mutants with impaired growth
in the presence of sodium deoxycholate, bacterial suspensions
were spotted onto MH agar plates supplemented with 1%
(wt/vol) sodium deoxycholate (Fig. 1). This concentration of
sodium deoxycholate reflects a physiologically relevant range
of bile salts present in human bile (25). A single mutant,
designated the cbrR mutant (for Camplyobacter bile resistance
regulator), failed to grow on the deoxycholate-supplemented
TABLE 2. Generation and phenotypic analysis of the C. jejuni
RR mutants
Gene Recovery of anull mutant Motility
a Deoxycholate
resistanceb
Cj0285c (cheV)   R
Cj0355c  NDc ND
Cj0643 (cbrR)   S
Cj0890c   R
Cj1024c (flgR)   R
Cj1118c (cheY)   R
Cj1223c (dccR)   R
Cj1227c  ND ND
Cj1261 (racR)   R
Cj1491   R
Cj1608   R
a , no migration of the C. jejuni strain on semisolid MH agar; , migration
of the C. jejuni mutant strain similar to that observed with the C. jejuni F38011
wild-type strain.
b R, C. jejuni mutant exhibits deoxycholate resistance; S, sensitive mutant.
c ND, not determined.
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plates and was chosen for further characterization. A comple-
mented cbrR strain was constructed by cloning the entire cbrR
wild-type allele and its native promoter into a shuttle vector
(pBR643). Transformation of pBR643 into the cbrR mutant
resulted in a complemented strain designated the cbrR(cbrR)
mutant.
To assess whether the cbrR mutant had altered growth ki-
netics when it was grown in sodium deoxycholate, we con-
structed a growth curve for a 30-h period in the presence or
absence of sodium deoxycholate. In preliminary experiments,
the addition of various concentrations (0.05 to 1%, wt/vol) of
sodium deoxycholate to MH broth was found to decrease the
growth rate of the C. jejuni F38011 strain compared to the
growth rate in MH broth alone. Therefore, we examined the
growth kinetics of the C. jejuni strains in broth containing a low
concentration of deoxycholate (0.05%, wt/vol). Consistent with
the results obtained in preliminary experiments, growth of the
C. jejuni F38011 wild-type strain and the cbrR and cbrR(cbrR)
strains was retarded in MH broth supplemented with 0.05%
(wt/vol) sodium deoxycholate (Fig. 2A). However, the growth
of the C. jejuni cbrR mutant in deoxycholate-supplemented
medium was severely impaired throughout the experiment
compared to the growth of the C. jejuni F38011 wild-type
strain. The sensitivity of the C. jejuni cbrR mutant to deoxy-
cholate was found to be specific to the cbrR gene, as comple-
mentation of the mutant with a wild-type copy of the gene in
trans restored the organism’s growth in 0.05% (wt/vol) deoxy-
cholate.
To determine if sodium deoxycholate had a bactericidal or
bacteriostatic effect on the C. jejuni cbrR mutant, bacteria were
cultured in the presence of 0.5% (wt/vol) sodium deoxycholate.
This concentration of sodium deoxycholate was chosen to as-
sess the mutant’s survival kinetics since the C. jejuni F38011
wild-type strain exhibited minimal growth under these condi-
tions. The viability of bacteria at various times was determined
by dilution plating. As shown in Fig. 2B, the viability of the C.
jejuni cbrR mutant steadily decreased over a 20-h experiment.
In contrast, the survival of the C. jejuni F38011 wild-type strain
and the cbrR(cbrR) complemented strain after 20 h of incu-
bation was greater than 80% based on the starting inoculum
(zero time). A significant difference was noted in the viability
of the C. jejuni cbrR mutant compared to that of the C. jejuni
F38011 wild-type strain at 10 and 20 h postinoculation (P 
0.01). These data indicate that the C. jejuni cbrR mutant was
killed in the presence of deoxycholate in a time-dependent
fashion. The rate of killing of the mutant was such that 50% of
FIG. 1. A C. jejuni F38011 cbrR (Cj0643) mutant fails to grow on deoxycholate-supplemented MH agar plates. Growth of response regulator
mutants on MH agar plates alone or MH agar plates supplemented with 1% sodium deoxycholate (MHD) was assessed by spotting 5 l of a
bacterial suspension which contained approximately 106 viable bacteria.
FIG. 2. Effect of sodium deoxycholate on the growth kinetics of C.
jejuni. (A) Growth (as determined by OD540) of the C. jejuni F38011
(■), cbrR (Œ), and cbrR(cbrR) (F) strains in MH broth (solid lines)
or MH broth supplemented with 0.05% sodium deoxycholate (dotted
lines). The data are from a single experiment that was representative
of three independent assays. (B) Survival (expressed as the number of
viable bacteria) of C. jejuni strains grown in the presence of 0.5%
sodium deoxycholate. Statistically significant differences (P  0.01) in
the survival of the C. jejuni wild-type strain and the cbrR mutant are
indicated by asterisks. The error bars indicate standard deviations.
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the initial inoculum survived for 5 h, yet only 0.01% of the
inoculum survived for 20 h.
The C. jejuni cbrRmutant is sensitive to bile salts. The MICs
of various detergents and antibiotics for the C. jejuni F38011
wild-type, cbrR, and cbrR(cbrR) strains were determined (Ta-
ble 3). Compared to the C. jejuni F38011 wild-type strain, the
C. jejuni cbrR mutant had a lower MIC for all bile salts tested,
including sodium deoxycholate, chenodeoxycholate, and cholic
acid. More specifically, the MIC of sodium deoxycholate for
the cbrR mutant was 16-fold lower than that for the wild-type
strain. Similarly, the MICs of the nonionic detergents Tween
20 and Triton X-100 were eightfold and fourfold lower for the
mutant, respectively. Growth of the cbrR mutant was inhibited
by 6,250 g/ml of ox bile extract, while for the wild-type strain
the MIC was 50,000 g/ml. The mutant displayed only a two-
fold difference in the MIC of SDS, an ionic detergent. In most
instances, the MIC for the complemented strain was identical
to that for the C. jejuni F38011 wild-type strain. For the C.
jejuni cbrR(cbrR) complemented strain, the MICs of Triton
X-100 and Tween 20 were intermediate between the MICs for
the C. jejuni F38011 wild-type and cbrR strains. The MICs of
both detergents for the complemented strain were only twofold
lower than those for the wild-type strain. No difference was
noted for any of the strains for the MICs of the antibiotics
tested, including nalidixic acid, tetracycline, and gentamicin.
The effect of osmolarity was tested by adding sodium chloride
to the medium. The MICs for the strains were identical (12,500
g/ml), and this concentration of sodium chloride is similar to
that reported by other workers as the maximum concentration
tolerated for growth of C. jejuni (14).
CbrR harbors multiple protein domains. Based on its nu-
cleotide sequence, the cbrR gene of C. jejuni NCTC 11168 is
capable of encoding a 414-amino-acid protein with a calculated
molecular mass of 47 kDa. In agreement with the calculated
mass, a protein with a similar size was observed (47 kDa)
when the cbrR gene from C. jejuni F38011 was expressed in E.
coli BL21 DE3 using the pET expression system (Novagen)
(not shown).
As stated above, the cbrR gene is not linked with a gene that
codes for a cognate HK. In addition, neighboring genes do not
provide obvious clues as to its function. For instance, the genes
immediately upstream of cbrR include Cj0641 (unknown func-
tion) and recN (encoding a DNA repair protein). Downstream,
cbrR appears to be translationally linked with Cj0644 (un-
known function), Cj0645 (encoding a probable secreted trans-
glycosylase), and Cj0646 (encoding a probable lipoprotein).
Analysis of the CbrR protein demonstrated that it contains
two tandem RR receiver domains and a C-terminal GGDEF
domain (Fig. 3A). Unlike the archetypical RR, CbrR lacks an
obvious DNA-binding motif. As CheY possesses a single well-
characterized receiver domain but no DNA-binding domain,
we aligned the individual CbrR receiver domains with E. coli
CheY. As shown in Fig. 3B, receiver domain I shows a high
degree of similarity with CheY. Highly conserved residues,
such as D12, D13, D57, T87, and K109 (relative to CheY
residue numbering), are maintained in domain I (39). Only two
residues, D57 and K109, are conserved in receiver domain II
(Fig. 3C). Interestingly, both receiver domains contain D57,
which is the likely site of phosphorylation (34); however, re-
ceiver domain II lacks the D12 and D13 resides that are in-
volved in the active site of CheY. At present, it is not clear
whether one or both receiver domains must be phosphorylated
for functioning or whether the protein simply phosphorylates
another RR.
Analysis of the CbrR protein also revealed a C-terminal
GGDEF domain. The GGDEF domain is found in various
bacterial signaling proteins and has been proposed to be a
diguanylate cyclase (5, 32). For example, two proteins in Ace-
tobacter xylinum possess a GGDEF motif, including a digua-
nylate cyclase and phosphodiesterase A (35). Both proteins are
involved in the regulation of cellulose biosynthesis. PleD of
Caulobacter crescentus exhibits 22% amino acid identity with
CbrR and contains two tandem N-terminal RR domains and a
C-terminal GGDEF motif. PleD is required for swarmer-to-
stalked cell transition (20) and regulates the onset of motility
prior to cell division (1). A multiple-sequence alignment of
PleD, the GGDEF consensus sequence derived from the
Pfam protein domain database (accession number PF00990;
http://www.sanger.ac.uk/Software/Pfam/index.shtml), and the
GGDEF domain of CbrR is shown in Fig. 3D. While many
conserved residues are present in CbrR (including D291, D293,
N299, D300, G303, G307, and D308), CbrR aligns poorly with
the GGDEF residues at amino acids 332 to 336 (17).
Finally, CbrR lacks an obvious DNA-binding domain and, as
TABLE 3. Sensitivity of C. jejuni strains to antimicrobial agents
Antimicrobial agent
MIC for C.
jejuni F38011
(g/ml)
C. jejuni cbrR mutant C. jejuni cbrR(cbrR) mutant
MIC (g/ml) Folddifferencea MIC (g/ml) Fold difference
a
Sodium deoxycholate 12,500 781 16 12,500 0
Sodium chenodeoxycholate 10,000 1,250 8 10,000 0
Cholic acid 3,125 781 4 3,125 0
Ox bile extract 50,000 6,250 8 25,000 2
Triton X-100 250 62.5 4 125 2
Tween 20 500 62.5 8 250 2
SDS 125 62.5 2 125 0
Nalidixic acid 12.5 12.5 0 12.5 0
Tetracycline 0.04 0.04 0 0.04 0
Gentamicin 0.781 0.781 0 0.781 0
Sodium chloride 12,500 12,500 0 12,500 0
a Fold difference in MIC for the C. jejuni cbrR or C. jejuni cbrR(cbrR) strain compared to the MIC for the C. jejuni F38011 wild-type strain.
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a result, may interact with another RR as part of a phosphore-
lay signaling cascade (which ultimately affects the transcription
of target genes) or directly with target proteins.
Chicken colonization. Given previous evidence that bile salt
resistance contributes to the colonization of chickens (28), we
tested the ability of the C. jejuni cbrR mutant to colonize
chickens. Colonization was compared for the C. jejuni wild-
type, cbrR, and cbrR(cbrR) strains. Two chicken colonization
experiments were performed. For each experiment, three
groups of chickens (15 chickens/group) were inoculated with
the C. jejuni F38011 wild-type strain, the cbrR mutant, or the
cbrR(cbrR) strain when the birds were 3 days old. At each
time, five chickens from each group were sacrificed and tested
for C. jejuni colonization.
In trial one, chickens were inoculated with 1.6 	 105 CFU of
C. jejuni F38011, 2.3 	 105 CFU of the cbrR strain, and 5.6 	
105 CFU of the cbrR(cbrR) strain. On day 3 postinoculation,
four of five of the C. jejuni F38011-inoculated chickens were
colonized (Fig. 4A). The extent of colonization ranged from 6
	 102 CFU/g feces to 6.5 	 104 CFU/g feces. Only one of the
chickens inoculated with the cbrR mutant was colonized (6.5 	
104 CFU/g feces). On day 6, all of the C. jejuni F38011-inoc-
ulated chickens were colonized (range, 5 	 103 to 1.0 	 107
CFU/g feces), but none of the chickens inoculated with the C.
jejuni cbrR mutant were colonized. On day 9, four of five
chickens inoculated with the C. jejuni F38011 wild-type strain
were colonized, while only a single chicken was colonized in
the group inoculated with the cbrR mutant. One of the birds
inoculated with the C. jejuni cbrR mutant died prior to nec-
ropsy on day 9. In this experiment, the C. jejuni cbrR(cbrR)
complemented strain failed to colonize chickens over the
course of the experiment.
The same experiment was repeated in trial two (Fig. 4B).
Three groups of birds were inoculated with 4	 106 CFU of the
C. jejuni F38011 wild-type strain, 4 	 106 CFU of the cbrR
strain, and 2 	 106 CFU of the cbrR(cbrR) strain. The C.
jejuni F38011 wild-type strain-inoculated birds were colonized
throughout the experiment at levels comparable to those in
trial one (range on day 3, 7 	 102 to 1 	 105 CFU/g feces),
while only two birds in the group inoculated with the cbrR
FIG. 3. Analysis of domains present in the CbrR protein. (A) Organization of domains in CbrR. (B) Amino acid sequence alignment of receiver
domain I with E. coli CheY. (C) Sequence alignment of receiver domain II with E. coli CheY. (D) Multiple-sequence alignment of the GGEFD
domain of CbrR with PleD (a GGEFD domain-containing protein of C. crescentus) and the GGEFD motif consensus sequence (Pfam accession
number 00990). The GGDEF residues are indicated by plus signs. The black background indicates identical amino acid residues, and the gray
background indicates similar residues. Conserved residues with respect to CheY or the GGDEF consensus sequence are indicated by asterisks.
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mutant showed a low level of colonization on day 9 (range, 1	
102 to 2 	102 CFU/g feces). A single chicken inoculated with
the C. jejuni wild-type strain died prior to necropsy on day 9. In
contrast to trial one, the C. jejuni cbrR(cbrR) strain did col-
onize some of the birds at levels similar to those observed with
the C. jejuni F38011 wild-type strain.
DISCUSSION
Intestinal pathogens must resist the antimicrobial effects of
bile as they pass through the upper small intestine, as well as
decreased levels in the lower intestine. The importance of
resistance to bile is illustrated by experiments with various
enteric bacteria. Bile resistance is required for intestinal colo-
nization in animal models by Listeria monocytogenes and V.
cholerae (8, 15). Salmonella enterica serovar Typhi can establish
persistent colonization of the gall bladder among carriers,
where it must be able to survive high concentrations of bile. C.
jejuni must be resistant to bile to colonize chickens via the
multidrug efflux pump CmeABC (28). Hence, an adaptive re-
sponse to bile has been shown to be important in virulence, and
there is evidence that two-component regulation is involved in
regulating this response.
In this study, we set out to generate knockout mutants with
mutations in RRs encoded by C. jejuni that may affect bile
resistance. We confirmed mutations in 9 of 11 RRs targeted.
We propose that one of the remaining genes, Cj0355c, may be
required for viability based on studies with HP1043 of H. pylori
(7). The failure to obtain a mutant with a mutation in Cj1227c
remains to be explained, but we were able to obtain a Cj1227
merodiploid that retained a copy of the wild-type allele. Con-
sistent with previous reports, we found that cheV, cheY, and
flgR mutants were nonmotile on semisolid agar (18, 26, 21, 22,
40, 42). The RR mutants were initially screened for growth on
MH agar plates supplemented with 1% sodium deoxycholate,
which is a high but subinhibitory concentration of this bile salt.
For C. jejuni, the MIC of sodium deoxycholate is approxi-
mately 1.25%. Only one C. jejuni mutant screened in this study,
the cbrR mutant, failed to grow on this medium. While it is
possible that other RR mutants display altered growth kinetics
in the presence of high concentrations of sodium deoxycholate,
we further examined the cbrR mutant as the mutation in the
cbrR locus had the most pronounced effect.
The C. jejuni cbrR mutant was unable to grow in the pres-
ence of a high concentration (1%, wt/vol) of sodium deoxy-
cholate, and growth was significantly inhibited at a low con-
centration (0.05%, wt/vol) of sodium deoxycholate. In contrast
to the C. jejuni F38011 wild-type strain, the C. jejuni cbrR
mutant was killed in the presence of sodium deoxycholate over
a 20-h experiment. In addition, ox bile extract, which contains
a mixture of bile salts, had an inhibitory effect on the growth of
the C. jejuni cbrR mutant compared to the growth of the wild-
type strain. The sensitivity of the C. jejuni cbrR mutant ap-
peared to be specific for detergents, and the greatest effect was
the effect of bile salts. Several mutations have been reported to
affect bile resistance in bacteria, including mutations in genes
that encode lipopolysaccharide, porins, efflux pumps, or regu-
latory genes (19). Such mutations may affect membrane access
(lipopolysaccharide) or transport of bile salts (porins and efflux
pumps). Regulatory genes, such as the genes encoding E. coli
RRs EvgA and BaeR, control expression of the multidrug
efflux pumps EmrKY and MdtABCD, respectively (6, 30). The
PhoPQ system is required for resistance to bile but not for
resistance to SDS or Triton X-100 in Salmonella spp. (38).
While bile affects the synthesis of many Salmonella proteins,
including those regulated by PhoPQ, no proteins were found to
mediate bile resistance directly.
In C. jejuni, the multidrug efflux pump, CmeABC, confers
resistance to a variety of antimicrobial agents, including bile
salts, antibiotics, and toxic compounds such as ethidium bro-
mide (27). CmeABC is subject to regulation by a local tran-
scriptional repressor, CmeR, which is encoded by a gene im-
mediately upstream of cmeABC (28a). CmeR binds specifically
to the inverted repeat sequences in the promoter of cmeABC
and modulates the expression of this efflux pump. It is note-
worthy that the promoter activity of cmeABC is bile salt induc-
ible and that induction is dependent on CmeR (Q. Zhang,
unpublished data). While there is no evidence that bile salts
affect CmeR binding, additional work is required to determine
if CbrR interacts with CmeR to modulate expression of Cme-
ABC. The mechanism of C. jejuni CbrR in the control of bile
resistance remains to be determined.
CbrR does not have an adjacent partner HK but may be-
come phosphorylated by one or more HKs encoded by C.
jejuni. Therefore, it is possible that at least one HK mutant
could display a deoxycholate-related phenotype. In a phos-
FIG. 4. Colonization of chickens by various Campylobacter strains.
Cecal contents were collected at necropsy on day 3, 6, or 9 postinocu-
lation. The data in panels A and B are the data from two independent
experiments. (A) Trial one. Chickens were inoculated with approxi-
mately 105 CFU of the C. jejuni F38011 (■), cbrR (‚), or cbrR(cbrR)
(F) strain. (B) Trial two. Chickens were inoculated with approximately
106 CFU of each C. jejuni strain. Each symbol indicates the log CFU/g
feces isolated from an inoculated chicken at a time postinoculation.
The mean log CFU/g feces for each group is indicated by a horizontal
bar.
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phorelay system, it is also likely that one or both of the receiver
domains of CbrR can transfer a phosphate to an alternate RR
or HK. However, it is not known whether CbrR transfers a
phosphate to a partner HK or RR. It is also possible that one
or both RR domains control the activity of the GGDEF do-
main in a manner similar to the phosphorylation of the RR
domain of CheB, which, in turn, activates a C-terminal meth-
ylesterase domain (3). Alternatively, CbrR may interact di-
rectly with another protein. Using a yeast two-hybrid approach,
at least 19 proteins that interact with CbrR have been identi-
fied (E. Dave and J. Ketley, Abstr. 104th Gen. Meet. Am. Soc.
Microbiol., abstr. H-059, 2004). It is not known whether mu-
tations in the target genes encoding these proteins result in
phenotypes similar to that of the C. jejuni cbrR mutant. Iden-
tification of other members of the CbrR regulon will likely aid
in characterization of the physiology of bile resistance in C.
jejuni. Target proteins with which CbrR interacts or proteins
whose expression is regulated by an RR that functions down-
stream of CbrR would likely play a more direct role in bile
resistance.
The GGDEF domain has been identified in a number of
multidomain regulatory proteins (17). The function of this
domain has been reported to be a diguanylate cyclase contain-
ing a putative nucleotide-binding loop (32, 35). Reports of
other proteins with a domain architecture similar to that of
CbrR (RR-RR-GGDEF) indicate that such proteins do not
have similar functions. One RR, PsfR of the cyanobacterium
Synechococcus elongatus, is involved in the regulation of circa-
dian expressed genes (37). The N-terminal RR domain of this
protein lacks the conserved aspartyl residue required for phos-
phorylation. Conversely, C. crescentus PleD lacks the aspartyl
residue in the C-terminal RR domain (20). Unlike either of
these proteins, CbrR contains an aspartyl residue in both RR
domains, suggesting that one or both domains may be phos-
phorylated. Another RR, RrpX of Aeromonas jandaei, allows
overexpression of the A. jandaei 
-lactamase, AsbB1, in E. coli
but not in A. jandaei (2). Using a conserved domain data-
base (http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?dbcdd),
we found that RrpX also contains the RR-RR-GGDEF archi-
tecture. Both RR domains appear to have the aspartyl residue
required for phosphorylation; however, the N-terminal RR
domain lacks a D12 residue, and the C-terminal RR domain
lacks a critical lysine residue (K109).
The C. jejuni cbrR mutant has a reduced ability to colonize
chickens, which may be due to its sensitivity to bile salts. Lin et
al. (28) reported that the concentration of bile salts in the
chicken intestine ranges from 0.085 mg/ml in the cecum to 7
mg/ml in the jejunum. In the present study, chicken coloniza-
tion was assessed by sampling cecal contents, where the con-
centration of bile is reportedly low; however, C. jejuni must
pass through the upper intestine, where the bile salt concen-
tration is higher than the MIC observed for the cbrR mutant
(1 mg/ml). We speculate that the high concentration of bile
in certain regions of the chicken digestive tract is sufficient to
kill the mutant before it colonizes the cecum. While not all
birds were colonized by the cbrR(cbrR) complemented strain
at a given time, those that were colonized had colonization
levels similar to that of birds inoculated with the C. jejuni
F38011 wild-type strain. The reason for the decreased number
of birds colonized by the complemented strain is unclear, as its
resistance to bile salts is similar to that of the C. jejuni F38011
wild-type strain. It is noteworthy that for the complemented
strain the MICs of nonionic detergents were intermediate be-
tween those for the C. jejuni F38011 wild-type strain and the
cbrR mutant. Hence, the complemented strain may retain sen-
sitivity to in vivo factors that were not tested in our in vitro
assays.
The identification of CbrR as a regulator of bile resistance in
C. jejuni is consistent with previous reports which showed that
bile resistance is required for chicken colonization (28). Future
studies will require identification and functional characteriza-
tion of a CbrR-protein partner(s) that affects bile resistance in
C. jejuni.
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